Nortriptyline toxicity secondary to interaction with bupropion sustained-release.
Weintraub
D
D
Norton Psychiatric Center, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, Kentucky, USA. daniel.weintraub@nortonhealthcare.org
D018759:Adrenergic Uptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism*; D000368:Aged; D000369:Aged, 80 and over; D016642:Bupropion / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D003865:Major Depressive Disorder / Q000188:drug therapy*; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D009661:Nortriptyline / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism*
D018759:Adrenergic Uptake Inhibitors; D003692:Delayed-Action Preparations; D018765:Dopamine Uptake Inhibitors; D016642:Bupropion; D009661:Nortriptyline